TheraRadar
Data updated: May 26, 2026

ADDERALL XR 10 (amphetamine aspartate)

CNS Approved 2001-10-11

ADDERALL XR 10 is indicated for the treatment of Attention Deficit Hyperactivity Disorder; Narcolepsy.

Source: FDA Label • Takeda
3
Indications
--
Phase 3 Trials
1
Priority Reviews
24
Years on Market

Details

Status
Prescription
First Approved
2001-10-11
Routes
ORAL
Dosage Forms
CAPSULE, EXTENDED RELEASE

ADDERALL XR 10 Approval History

2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
25 FDA actions from 2001 to 2026 · 2 indication expansions
Apr 2026 SUPPL
Label · Labeling
Sep 2025 SUPPL
Label · Labeling
Oct 2023 SUPPL
Label · Labeling

What ADDERALL XR 10 Treats

2 indications

ADDERALL XR 10 is approved for 2 conditions since its original approval in 2001. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Attention Deficit Hyperactivity Disorder
  • Narcolepsy
Source: FDA Label

ADDERALL XR 10 Boxed Warning

ABUSE, MISUSE, AND ADDICTION DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE TABLETS has a high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction. Misuse and abuse of CNS stimulants, including DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE TABLETS, can result in overdose and death (see OVERDOSAGE), and this risk is increas...

ADDERALL XR 10 Competitive Set

Pro

Three rings of competition based on shared molecular targets and treated indications.

Unlock 8 more competitors across all three rings.
Upgrade to Pro

Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.

Drugs Similar to ADDERALL XR 10

3 of 20

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

ADDERALL XR 15
AMPHETAMINE ASPARTATE
2 shared
Takeda
ADDERALL XR 20
AMPHETAMINE ASPARTATE
2 shared
Takeda
ADDERALL XR 25
AMPHETAMINE ASPARTATE
2 shared
Takeda
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

ADDERALL XR 10 FDA Label Details

Indications & Usage

FDA Label (PDF)

ADDERALL XR 10 is indicated for the treatment of Attention Deficit Hyperactivity Disorder; Narcolepsy.

⚠️ BOXED WARNING

WARNING: ABUSE, MISUSE, AND ADDICTION DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE TABLETS has a high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction. Misuse and abuse of CNS ...

Track ADDERALL XR 10 with TheraRadar Pro

Watchlist alerts, full database access, CSV exports across 14,000+ drugs.

Upgrade to Pro

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.